Skip to main content
. 2017 Oct 23;167(3):671–686. doi: 10.1007/s10549-017-4537-5

Fig. 3.

Fig. 3

Percent change in target lesions from baseline in 46 evaluable patients with TNBC with baseline tumor assessment and ≥ 1 post-baseline assessment